Tumor marker

A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one or more types of cancer. There are many different tumor markers, each indicative of a particular disease process, and they are used in oncology to help detect the presence of cancer. An elevated level of a tumor marker can indicate cancer; however, there can also be other causes of the elevation (false positive values).

Tumor markers can be produced directly by the tumor or by non-tumor cells as a response to the presence of a tumor.

Although mammography, ultrasonography, computed tomography, magnetic resonance imaging scans, and tumor marker assays help in the staging and treatment of the cancer, they are usually not definitive diagnostic tests. The diagnosis is mostly confirmed by biopsy.

Classification

On the basis of their chemical nature tumor markers can be proteins, conjugated proteins, peptides or carbohydrates. Proteins or conjugated proteins may be enzymes, hormones or fragments of proteins. Sequencing of genes for diagnostic purposes is mostly classified under the biomarker heading and is not treated here.

Podcasts:

PLAYLIST TIME:

Latest News for: tumor marker

Bone Metastasis Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Statistics, Revenue, ...

GetNews 28 Mar 2025
Diagnosis typically involves imaging techniques such as X-rays, MRI, CT scans, and bone scans, alongside blood tests measuring tumor markers and calcium levels.

From Colonoscopy to At-Home Tests: Health First’s Dr. Ritesh Patil Details Screening Options That Could ...

Space Coast Daily 27 Mar 2025
Patil explained that follow-up includes repeat colonoscopies, regular imaging scans (such as CT scans), and blood tests for tumor markers like carcinoembryonic antigen (CEA) which is a protein made by some types of cancer including bowel cancer.

Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development

Pharmiweb 26 Mar 2025
These tumors produce unique markers, FSPs, which serve as tumor-specific neoantigens ... These tumors produce unique markers known as frameshift peptides (FSPs), which are unique to the cancer and absent in healthy cells.

CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme

ACCESSWIRE 25 Mar 2025
However, although the trial was not powered to determine non-inferiority, the data appear comparable in clinically important endpoints in all patients, including those with the most unfavorable tumor markers.

I was diagnosed with stage 4 cancer and given a year to live at age ...

The Daily Mail 21 Mar 2025
While she has reached the very last medical option – new treatment Enhertu started three months ago – her pain has gone away, the metastases in her lungs have disappeared, her liver is shrinking again, and her tumor markers are coming down.

Blood test for ovarian cancer misses some Black and Native American patients, study finds

Boston Herald 21 Mar 2025
By CARLA K. JOHNSON ... Researchers have been working to uncover these kinds of biases in medicine ... The test measures a tumor marker in the blood, and doctors use it to determine if a woman with a suspicious lump should be referred to a cancer specialist.

Debrecen University Acquires World-Class CT Scanner

Hungary Today 17 Mar 2025
The idea is to combine a diagnostic marker with a therapeutic procedure, which can then target a tumor, in this case a brain tumor, with great efficiency.

Mapping the Shift from Healthy Stem Cells to Oral Cancer

The Scientist 12 Mar 2025
Gutkind and his team focused on HPV-positive oral cancer, which involves the loss of function of two key tumor suppressor genes, tumor protein 53 and cyclin-dependent kinase inhibitor 2A ... Gutkind was surprised by how quickly the tumors formed.

Global Point-of-Care Diagnostics Market Poised for Growth Amid Rising Chronic and Infectious Diseases

Pharmiweb 11 Mar 2025
The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8% ... Technological Innovations Driving Market Expansion ... Abbott Laboratories ... Tumor/Cancer Marker Testing Products ... .
  • 1
×